Underweight and obesity as outcome predictors after transcatheter aortic valve implantation: insights from the DOUBLE-CHOICE trial
Year: 2026
Type: article
Abstract: Background An “obesity paradox” has been described after transcatheter aortic valve implantation (TAVI), suggesting lower mortality in patients with higher body mass index (BMI) despite greater comorbidity. In contrast, underweight consistently predicts adverse outcomes. Whether these associations reflect a true biological effect or are primarily driven by residual confounding, frailty, and patient selection remains uncertain. Methods This prespecified subgroup analysis included eligible patients from the randomized DOUBLE-CHOICE trial comparing two transcatheter heart valves and two anesthesia strategies (minimalist approach with local anesthesia only vs. standard care with conscious sedation). The primary endpoint was a 30-day composite of all-cause mortality, vascular and bleeding complications, infections requiring antibiotic therapy, and neurologic events. Associations were evaluated using multivariable logistic regression adjusted for age, sex, frailty, diabetes, hypertension, chronic kidney disease, and anesthesia strategy. Results Among 752 patients (BMI ≥ 30 kg/m 2 , n = 192; BMI < 30 kg/m 2 , n = 560), obese patients had lower rates of the 30-day primary endpoint (15.2% vs. 27.6%; p < 0.001). After multivariable adjustment, obesity remained independently associated with lower risk (adjusted OR 0.48, 95% CI 0.30–0.75; p = 0.002). In contrast, underweight (BMI < 20 kg/m 2 ; n = 23) was associated with a higher incidence of the primary endpoint (55.0% vs. 23.4%; p = 0.003) and remained an independent predictor after adjustment (adjusted OR 3.74, 95% CI 1.30–9.52; p = 0.005). Conclusion In this randomized TAVI population, obesity was independently associated with favorable 30-day outcomes, whereas underweight identified a small but high-risk subgroup with substantially increased procedural risk. These findings identify underweight as a potential high-risk phenotype requiring further investigation in future studies incorporating more detailed measures of frailty and body composition.
Source: Clinical Research in Cardiology
Authors: Maria Buske, Mohamed Abdel-Wahab, Joerg Ender, Steffen Desch, Niklas Lankisch, Helene Schrader, Sebastian von der Emde, Philipp Lauten, Tanja K. Rudolph, Tobias Geisler, Steffen Massberg, Matti Adam, Stephan Baldus, Samuel Sossalla, Michael Joner, Helge Möllmann, Alexander Wolf, Won-Keun Kim, Michael A. Borger, Thilo Noack, Andreas Boening, Sabine Bleiziffer, Sven Hohenstein, Holger Thiele, Hans-Josef Feistritzer
Institutions: Leipzig Heart Institute, Leipzig University, Zentralklinik Bad Berka, Heart and Diabetes Center North Rhine-Westphalia, Universitätsklinikum Tübingen, Ludwig-Maximilians-Universität München, University of Cologne, Universitätsklinikum Gießen und Marburg, Deutsches Herzzentrum München, Technical University of Munich, St.-Johannes-Hospital Dortmund, Witten/Herdecke University, Helios Park-Klinikum Leipzig, University Hospital Leipzig
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,190
Awards: G4075341674, G9001360304
OpenAlex ID: W7225875179
